[ET Net News Agency, 10 March 2026] HANSOH PHARMA (03692) rose 3.1% to HK$34.78.
It hits an intra-day high of HK$34.78, breaking above the 10-D SMA of HK$33.8, and an
intra-day low of HK$33.64. The total shares traded was 1.3 million, with a value of
HK$44.91m. The active buy/sell ratio is 74:26, with net buying turnover of HK$19.49m.
GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$1.02m,
with volume weighted average price of HK$34.554. TFI SEC & FUTURES accounts for greatest
net responsive selling turnover of HK$3.35m, with volume weighted average price of
HK$34.515. The stock has risen a combined 8.7% over the past 4 consecutive trading days.
The Hang Seng Index now rose 397 points, or 1.6% to 25,805.

Basic Information
=================

---------------------------------
Nominal 34.780 % Chg +3.14%
High 34.780 Low 33.640
Shares Tr 1.3m Turnover 44.91m
10-D SMA 33.800 %H.V 37.526
20-D SMA 35.295 VWAP 34.428
50-D SMA 37.667 RSI14 44.953
---------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 74:26, with net buying
turnover of HK$19.49m, rising a combined 8.7% over the past 4 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 34.78 +3.14
SIHUAN PHARM (00460) 1.51 +2.72
GRAND PHARMA (00512) 7.37 +2.65
SINO BIOPHARM (01177) 6.25 +1.30
HENGRUI PHARMA (01276) 66.55 +2.78
LIVZON PHARMA (01513) 28.80 +0.49
LUYE PHARMA (02186) 2.50 +1.63
FOSUN PHARMA (02196) 20.02 +2.35
SH PHARMA (02607) 11.40 +0.71
CHINARES PHARMA (03320) 4.57 +0.44
-----------------------------------------------
(ed)